课题基金 / 基金详情

A5132 TRIAL TO EVALUATE INTERLEUKIN-2 (IL-2) POTENT ANTIRETROVIRAL THERAPY

A5132 TRIAL TO EVALUATE INTERLEUKIN-2 (IL-2) POTENT ANTIRETROVIRAL THERAPY
A5132 评估白细胞介素 2 (IL-2) 有效抗逆转录病毒治疗的试验
批准号:
7605184
负责人:
THOMAS C MERIGAN
金额:
$0.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-02-15 至 2007-11-30

项目摘要

项目成果

THOMAS C MERIGAN的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. A5132 is an exploratory, open-label, randomized trial to evaluate the ability of IL-2 to enhance HIV-specific immune responses and influence the rate of virologic rebound following potent antiretroviral therapy (ART) interruptions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MANAGEMENT OF HEPATITIS C VIRUS (HCV) AND HIV-1 CO-INFECTED SUBJECTS
  • 批准号:
    7605200
  • 项目类别:
  • 资助金额:
    $4.74万
  • 财政年份:
    2007
  • 负责人:
    THOMAS C MERIGAN
  • 依托单位:
DETERMINE TIME TO DEVELOPMENT OF AIDS DEFINING COMPLICATIONS & INFECTIONS
  • 批准号:
    7605165
  • 项目类别:
  • 资助金额:
    $2.09万
  • 财政年份:
    2007
  • 负责人:
    THOMAS C MERIGAN
  • 依托单位:
ANTIVIRAL MANAGEMENT OF HEPATITIS C VIRUS AND HIV-1 CO-INFECTED SUBJECTS
  • 批准号:
    7375261
  • 项目类别:
  • 资助金额:
    $6.32万
  • 财政年份:
    2005
  • 负责人:
    THOMAS C MERIGAN
  • 依托单位:
HIV SUBJECTS WITH DECREASED BONE MINERAL DENSITY RECEIVING CALCIUM AND VITAMIN D
  • 批准号:
    7375239
  • 项目类别:
  • 资助金额:
    $0.89万
  • 财政年份:
    2005
  • 负责人:
    THOMAS C MERIGAN
  • 依托单位:
海外基金